Insider Shareholders with Direct Ownership of Artiva Biotherapeutics, Inc. (RTVA)
This section provides a comprehensive overview of the insiders with direct ownership of Artiva Biotherapeutics, Inc. (RTVA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Artiva Biotherapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 1,936,637 | 0 | 1,936,637 | 1 |
Jul 22, 2024
Added 17.71%
|
|
|
Fred Aslan
President and CEO |
428,905 | 34,444 | 382,221 | 4 |
Aug 15, 2025
Reduced 1.16%
|
| 194,108 | 0 | 194,108 | 1 |
Jul 22, 2024
Added 20.16%
|
|
|
Jennifer Bush
COO, CLO, Secy, Compliance Off |
136,650 | 8,346 | 151,103 | 4 |
Aug 15, 2025
Reduced 4.07%
|
|
Neha Krishnamohan
Chief Financial Officer |
110,000 | 7,154 | 102,846 | 4 |
Aug 15, 2025
Reduced 5.35%
|
|
Christopher Horan
Chief Tech Operations Officer |
85,000 | 4,918 | 80,082 | 4 |
Aug 15, 2025
Reduced 4.28%
|
|
Thorsten Graef
Chief Medical Officer |
80,000 | 0 | 80,000 | 2 |
Feb 26, 2025
Added 42.86%
|
|
Subhashis Banerjee
Chief Medical Officer |
50,000 | 0 | 50,000 | 1 |
Apr 08, 2025
Added 50.0%
|
|
Heather Raymon
SVP, Research and Development |
43,350 | 2,384 | 40,966 | 4 |
Aug 15, 2025
Reduced 3.85%
|
| 2,958,063 | 0 | 0 | 1 |
N/A
|